Michael E. Mullendore

4.9k total citations · 2 hit papers
21 papers, 3.7k citations indexed

About

Michael E. Mullendore is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael E. Mullendore has authored 21 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Michael E. Mullendore's work include Hedgehog Signaling Pathway Studies (5 papers), MicroRNA in disease regulation (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Michael E. Mullendore is often cited by papers focused on Hedgehog Signaling Pathway Studies (5 papers), MicroRNA in disease regulation (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Michael E. Mullendore collaborates with scholars based in United States, Netherlands and Germany. Michael E. Mullendore's co-authors include Georg Feldmann, Anirban Maitra, Joshua T. Mendell, Oliver A. Kent, Erik A. Wentzel, Dan E. Arking, Charles J. Lowenstein, Munekazu Yamakuchi, Marcella Ferlito and M Beer and has published in prestigious journals such as Genes & Development, Molecular Cell and Cancer Research.

In The Last Decade

Michael E. Mullendore

21 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

2007 1.6k citations Tsung-Cheng Chang, Erik A. Wentzel et al. Molecular Cell profile →
Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers

2007 537 citations Georg Feldmann, Surajit Dhara et al. Cancer Research profile →

Peers

Countries citing papers authored by Michael E. Mullendore

Since Specialization

Citations

This map shows the geographic impact of Michael E. Mullendore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Mullendore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Mullendore more than expected).

Fields of papers citing papers by Michael E. Mullendore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Mullendore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Mullendore. The network helps show where Michael E. Mullendore may publish in the future.

Co-authorship network of co-authors of Michael E. Mullendore

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Mullendore. A scholar is included among the top collaborators of Michael E. Mullendore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Mullendore. Michael E. Mullendore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide 2021 ·Oncotarget ·Lara H. El Touny, Curtis Hose, John Connelly, Erik Harris, Anne Monks, (unknown), Deborah Wilsker, Melinda G. Hollingshead, (unknown), Sergio Y. Alcoser, Michael E. Mullendore, Ralph E. Parchment, James H. Doroshow, Beverly A. Teicher, Annamaria Rapisarda	8
2	Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies 2014 ·BMC Genomics ·Melinda G. Hollingshead, Luke H. Stockwin, Sergio Y. Alcoser, Dianne L. Newton, Benjamin C. Orsburn, Carrie Bonomi, Suzanne Borgel, (unknown), (unknown), Elizabeth Hager, Susan L. Holbeck, Gurmeet Kaur, (unknown), Mark W. Kunkel, (unknown), Michael E. Mullendore, Howard Stotler, Jerry M. Collins	26
3	The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response 2012 ·Cancer Chemotherapy and Pharmacology ·Trevor Glaros, Luke H. Stockwin, Michael E. Mullendore, Brian A. Smith, (unknown), Dianne L. Newton	83
4	Abstract 2810: NSC 743380 induces apoptosis in sensitive cell lines through activation of tyrosine kinase 2 (Tyk2) 2012 ·Cancer Research ·Dianne L. Newton, Luke H. Stockwin, Michael E. Mullendore, Bingnan Han, (unknown), Suzanne Borgel, Howard Stotler, Bingliang Fang, Melinda G. Hollingshead	1
5	Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway 2010 ·Genes & Development ·Oliver A. Kent, Raghu R. Chivukula, Michael E. Mullendore, Erik A. Wentzel, Georg Feldmann, Kwang H. Lee, Shu Liu, Steven D. Leach, Anirban Maitra, Joshua T. Mendell	255
6	Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer 2009 ·Clinical Cancer Research ·Michael E. Mullendore, (unknown), Yue‐Ming Li, G. J. A. Offerhaus, Xing Fan, Clark M. Henderson, William Matsui, Charles G. Eberhart, Anirban Maitra, Georg Feldmann	150
7	MicroRNA miR-155 is a biomarker of early pancreatic neoplasia 2009 ·Cancer Biology & Therapy ·Nils Habbe, (unknown), Joshua T. Mendell, G. Johan A. Offerhaus, Ji Kon Ryu, Georg Feldmann, Michael E. Mullendore, Michael Goggins, Seung‐Mo Hong, Anirban Maitra	243
8	A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells 2009 ·Cancer Biology & Therapy ·Oliver A. Kent, Michael E. Mullendore, (unknown), Pedro López‐Romero, Aik Choon Tan, (unknown), Kristen M. West, Michael F. Ochs, Manuel Hidalgo, Dan E. Arking, Anirban Maitra, Joshua T. Mendell	95
9	Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer 2008 ·Clinical Cancer Research ·Héctor M. Álvarez, Alejandro H. Corvalán, Juan Carlos Roa, Pedram Argani, F. Murillo, Jennifer B. Edwards, Robert M. Beaty, Georg Feldmann, Seung‐Mo Hong, Michael E. Mullendore, Iván Roa, Luis Ibáñez, Fernando Pimentel, (unknown), Gregory J. Riggins, Anirban Maitra	33
10	Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer 2008 ·Gut ·Georg Feldmann, Nils Habbe, (unknown), Savita Bisht, Héctor M. Álvarez, V. Fendrich, Robert M. Beaty, Michael E. Mullendore, Collins Karikari, Nabeel Bardeesy, Michel M. Ouellette, Wei Yu, Anirban Maitra	146
11	In vivocharacterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities 2008 ·Molecular Cancer Therapeutics ·Savita Bisht, Georg Feldmann, (unknown), Michael E. Mullendore, Héctor M. Álvarez, Collins Karikari, Michelle A. Rudek, (unknown), Amarnath Maitra, Anirban Maitra	50
12	MICRORNA MIR-155 IS A BIOMARKER OF EARLY PANCREATIC NEOPLASIA 2008 ·Pancreas ·Nils Habbe, (unknown), Jeanne Mendell, G. Johan A. Offerhaus, Ji Kon Ryu, Georg Feldmann, Michael E. Mullendore, Michael Goggins, Seung‐Mo Hong, Anirban Maitra	15
13	An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer 2008 ·Molecular Cancer Therapeutics ·Georg Feldmann, Volker Fendrich, Karen McGovern, Djahida Bedja, Savita Bisht, Héctor M. Álvarez, (unknown), Nils Habbe, Collins Karikari, Michael E. Mullendore, Kathleen L. Gabrielson, Rajni Sharma, William Matsui, Anirban Maitra	200
14	Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers breakdown → 2007 ·Cancer Research ·Georg Feldmann, Surajit Dhara, Volker Fendrich, Djahida Bedja, Robert M. Beaty, Michael E. Mullendore, Collins Karikari, Héctor M. Álvarez, Christine A. Iacobuzio–Donahue, Antonio Jimeno, Kathleen L. Gabrielson, William Matsui, Anirban Maitra	537
15	Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis breakdown → 2007 ·Molecular Cell ·Tsung-Cheng Chang, Erik A. Wentzel, Oliver A. Kent, (unknown), Michael E. Mullendore, Kwang Hyuck Lee, Georg Feldmann, Munekazu Yamakuchi, Marcella Ferlito, Charles J. Lowenstein, Dan E. Arking, M Beer, Anirban Maitra, Joshua T. Mendell	1627
16	Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum 2007 ·Endocrine Related Cancer ·Volker Fendrich, Jens Waldmann, Farzad Esni, Annette Ramaswamy, Michael E. Mullendore, Malte Buchholz, Anirban Maitra, Georg Feldmann	59
17	Mitochondrial DNA Mutations in Pancreatic Cancer 2006 ·International Journal of Gastrointestinal Cancer ·(unknown), Nils Habbe, Michael E. Mullendore, Collins Karikari, Anirban Maitra, Georg Feldmann	29
18	Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers 2005 ·Molecular Cancer Therapeutics ·Collins Karikari, Michael E. Mullendore, James R. Eshleman, Pedram Argani, Lorenzo M. Leoni, Shrikanta Chattopadhyay, Manuel Hidalgo, Anirban Maitra	30
19	Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy 2002 ·BMC Physiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael E. Mullendore, (unknown)	49
20	The NADH oxidase from Pyrococcus furiosus 2001 ·European Journal of Biochemistry ·Donald E. Ward, Christopher J. Donnelly, Michael E. Mullendore, John van der Oost, Willem M. de Vos, Edward J. Crane	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact